Aurobindo Pharma Board Meeting Outcome
Aurobindo Pharma's Board approved a ₹800 Crore share buyback at ₹1,475 per share via the tender offer route. The buyback represents 0.93% of paid-up equity capital. The record date is set for April 17, 2026, to determine eligibility for shareholders, including promoters.
- Value
- ₹800.0 Cr